114 related articles for article (PubMed ID: 15526202)
1. Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport system.
Nagai K; Nagasawa K; Fujimoto S
Cancer Chemother Pharmacol; 2005 Mar; 55(3):222-30. PubMed ID: 15526202
[TBL] [Abstract][Full Text] [Related]
2. Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells.
Nagai K; Nagasawa K; Ishimoto A; Fujimoto S
Cancer Chemother Pharmacol; 2003 Jun; 51(6):512-8. PubMed ID: 12679883
[TBL] [Abstract][Full Text] [Related]
3. Contribution of an unidentified sodium-dependent nucleoside transport system to the uptake and cytotoxicity of anthracycline in mouse M5076 ovarian sarcoma cells.
Nagai K; Nagasawa K; Koma M; Kihara Y; Fujimoto S
Biochem Pharmacol; 2006 Feb; 71(5):565-73. PubMed ID: 16376308
[TBL] [Abstract][Full Text] [Related]
4. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
[TBL] [Abstract][Full Text] [Related]
5. Uptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells.
Borgland SL; Parkinson FE
J Pharmacol Exp Ther; 1997 Apr; 281(1):347-53. PubMed ID: 9103516
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside transport at the blood-testis barrier studied with primary-cultured sertoli cells.
Kato R; Maeda T; Akaike T; Tamai I
J Pharmacol Exp Ther; 2005 Feb; 312(2):601-8. PubMed ID: 15547112
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside transporter expression and function in cultured mouse astrocytes.
Peng L; Huang R; Yu AC; Fung KY; Rathbone MP; Hertz L
Glia; 2005 Oct; 52(1):25-35. PubMed ID: 15892125
[TBL] [Abstract][Full Text] [Related]
8. Cytidine is a novel substrate for wild-type concentrative nucleoside transporter 2.
Nagai K; Nagasawa K; Koma M; Hotta A; Fujimoto S
Biochem Biophys Res Commun; 2006 Aug; 347(2):439-43. PubMed ID: 16828706
[TBL] [Abstract][Full Text] [Related]
9. Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin.
Sugiyama T; Sadzuka Y; Nagasawa K; Ohnishi N; Yokoyama T; Sonobe T
Jpn J Cancer Res; 1999 Jul; 90(7):775-80. PubMed ID: 10470291
[TBL] [Abstract][Full Text] [Related]
10. Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells.
Nagasawa K; Ohnishi N; Yokoyama T
Jpn J Cancer Res; 1998 Jun; 89(6):673-80. PubMed ID: 9703366
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment.
Sadzuka Y; Hatakeyama H; Sonobe T
Int J Pharm; 2010 Jan; 383(1-2):186-91. PubMed ID: 19732815
[TBL] [Abstract][Full Text] [Related]
12. Transport of physiological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombinant Escherichia coli nucleoside-H(+) cotransporter (NupC) produced in Xenopus laevis oocytes.
Loewen SK; Yao SY; Slugoski MD; Mohabir NN; Turner RJ; Mackey JR; Weiner JH; Gallagher MP; Henderson PJ; Baldwin SA; Cass CE; Young JD
Mol Membr Biol; 2004; 21(1):1-10. PubMed ID: 14668133
[TBL] [Abstract][Full Text] [Related]
13. Effects of glutamate transporter inhibitors on the antitumor activity of doxorubicin.
Sadzuka Y; Yamashita Y; Sonobe T
Clin Cancer Res; 2002 Dec; 8(12):3943-7. PubMed ID: 12473610
[TBL] [Abstract][Full Text] [Related]
14. Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.
Sadzuka Y; Sugiyama T; Suzuki H; Sawanishi H; Miyamoto K
Toxicol Lett; 2004 May; 150(3):341-9. PubMed ID: 15110086
[TBL] [Abstract][Full Text] [Related]
15. Transport characteristics of mouse concentrative nucleoside transporter 1.
Niitani M; Nishida K; Okuda H; Nagai K; Fujimoto S; Nagasawa K
Int J Pharm; 2010 Mar; 388(1-2):168-74. PubMed ID: 20060452
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells.
Nagasawa K; Fumihara T; Ohnishi N; Yokoyama T
Jpn J Cancer Res; 1999 Jul; 90(7):781-7. PubMed ID: 10470292
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mENT1Delta11, a novel alternative splice variant of the mouse equilibrative nucleoside transporter 1.
Robillard KR; Bone DB; Park JS; Hammond JR
Mol Pharmacol; 2008 Jul; 74(1):264-73. PubMed ID: 18413666
[TBL] [Abstract][Full Text] [Related]
18. Functional and pharmacological mechanisms of nucleoside transport across the basolateral membrane of rabbit tracheal epithelial cells.
Wu SK; Mathias NR; Kim KJ; Lee VH
Life Sci; 2005 Dec; 78(3):310-20. PubMed ID: 16111717
[TBL] [Abstract][Full Text] [Related]
19. The concentrative nucleoside transporter family (SLC28): new roles beyond salvage?
Aymerich I; Duflot S; Fernández-Veledo S; Guillén-Gómez E; Huber-Ruano I; Casado FJ; Pastor-Anglada M
Biochem Soc Trans; 2005 Feb; 33(Pt 1):216-9. PubMed ID: 15667311
[TBL] [Abstract][Full Text] [Related]
20. Allelic isoforms of the H+/nucleoside co-transporter (CaCNT) from Candida albicans reveal separate high- and low-affinity transport systems for nucleosides.
Slugoski MD; Loewen SK; Ng AM; Baldwin SA; Cass CE; Young JD
Yeast; 2004 Nov; 21(15):1269-77. PubMed ID: 15543539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
